UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 161

Sortiert nach

Caffeic acid phenethyl ester prevents 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced neurodegeneration

Neuroscience, 2011-08, Vol.188, p.135-141

2011

Volltextzugriff (PDF)

Intravenous immunoglobulins containing antibodies against β-amyloid for the treatment of Alzheimer’s disease

Journal of neurology, neurosurgery and psychiatry, 2004-10, Vol.75 (10), p.1472-1474

2004

Volltextzugriff (PDF)

Caffeic acid phenethyl ester prevents cerebellar granule neurons (CGNs) against glutamate-induced neurotoxicity

Neuroscience, 2008-09, Vol.155 (4), p.1098-1105

2008

Volltextzugriff (PDF)

Association of an interleukin 1 alpha polymorphism with Alzheimer's disease

Neurology, 2000-08, Vol.55 (4), p.480

2000

Volltextzugriff (PDF)

Assessing health-related quality of life in patients with Parkinson's disease in a prospective longitudinal study

Parkinsonism & related disorders, 2007-03, Vol.13 (2), p.108-114

2007

Volltextzugriff (PDF)

Pharmacotherapy of Parkinson's disease in Germany

Journal of neurology, 2005-08, Vol.252 (8), p.926-935

2005

Volltextzugriff (PDF)

Evaluation of healthcare utilization and health status of patients with Parkinson's disease treated with deep brain stimulation of the subthalamic nucleus

Journal of neurology, 2002-06, Vol.249 (6), p.759-766

2002

Volltextzugriff (PDF)

Minocycline Prevents Nigrostriatal Dopaminergic Neurodegeneration in the MPTP Model of Parkinson's Disease

Proceedings of the National Academy of Sciences - PNAS, 2001-12, Vol.98 (25), p.14669-14674

2001

Volltextzugriff (PDF)

Activation mapping in essential tremor with functional magnetic resonance imaging

Annals of neurology, 1997-01, Vol.41 (1), p.32-40

1997

Volltextzugriff (PDF)

Involvement of a Caspase‐3‐Like Cysteine Protease in 1‐Methyl‐4‐Phenylpyridinium‐Mediated Apoptosis of Cultured Cerebellar Granule Neurons

Journal of neurochemistry, 1997-10, Vol.69 (4), p.1382-1388

1997

Volltextzugriff (PDF)

Peptide inhibitors of caspase-3-like proteases attenuate 1-methyl-4-phenylpyridinum-induced toxicity of cultured fetal rat mesencephalic dopamine neurons

Neuroscience, 1998-10, Vol.86 (3), p.701-707

1998

Volltextzugriff (PDF)

Health-related quality of life and healthcare utilisation in patients with Parkinson's disease: Impact of motor fluctuations and dyskinesias

PharmacoEconomics, 2001, Vol.19 (10), p.1013-1038

2001

Volltextzugriff (PDF)

A polymorphism in the cystatin C promoter region is not associated with an increased risk of AD

Neurology, 2002-02, Vol.58 (4), p.664

2002

Volltextzugriff (PDF)

Lack of apolipoprotein E dramatically reduces amyloid β-peptide deposition

Nature genetics, 1997-11, Vol.17 (3), p.263-264

1997

Volltextzugriff (PDF)

Costs of drug treatment in Parkinson's disease

Movement disorders, 1998-03, Vol.13 (2), p.249-254

1998

Volltextzugriff (PDF)

Activation of a Caspase 3-Related Cysteine Protease is Required for Glutamate-Mediated Apoptosis of Cultured Cerebellar Granule Neurons

Proceedings of the National Academy of Sciences - PNAS, 1997-10, Vol.94 (21), p.11657-11662

1997

Volltextzugriff (PDF)

The NF- κB/Rel family of proteins mediates A β-induced neurotoxicity and glial activation

Brain research. Molecular brain research., 1998-06, Vol.57 (1), p.63-72

1998

Volltextzugriff (PDF)

Long-term disease-related costs 4 years after stroke or TIA in Germany

Nervenarzt, 2008-08, Vol.79 (8), p.918-926

2008

Volltextzugriff (PDF)

Caspase-3-like proteases and 6-hydroxydopamine induced neuronal cell death

Brain research. Molecular brain research., 1999-01, Vol.64 (1), p.141-148

1999

Volltextzugriff (PDF)

International guide to drugs for Parkinson's disease

Movement disorders, 1995-03, Vol.10 (2), p.121-131

1995

Volltextzugriff (PDF)

The economic impact of Parkinson's disease. An estimation based on a 3-month prospective analysis

PharmacoEconomics, 1998-09, Vol.14 (3), p.299-312

1998

Volltextzugriff (PDF)

Characterization of histamine receptors in the ureter of the dog

European journal of pharmacology, 1996-12, Vol.318 (2), p.395-402

1996

Volltextzugriff (PDF)

Langzeitkrankheitskosten 4 Jahre nach Schlaganfall oder TIA in Deutschland

Nervenarzt, 2008-08, Vol.79 (8), p.918-926

2008

Volltextzugriff (PDF)

Apolipoprotein E is essential for amyloid deposition in the APP(V717F) transgenic mouse model of Alzheimer's disease

Proceedings of the National Academy of Sciences - PNAS, 1999-12, Vol.96 (26), p.15233-15238

1999

Volltextzugriff (PDF)

New approaches to rapid onset antidepressants

Current pharmaceutical design, 1998-08, Vol.4 (4), p.291

1998

Volltextzugriff (PDF)

1 – 25 von 161

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(155)
Mit Volltextzugriff
(143)

Publikationsform

Sprache

Englisch
(132)
Deutsch
(26)
Japanisch
(13)
Spanisch
(1)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Caffeic acid phenethyl ester prevents 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced neurodegeneration

Intravenous immunoglobulins containing antibodies against β-amyloid for the treatment of Alzheimer’s disease

Caffeic acid phenethyl ester prevents cerebellar granule neurons (CGNs) against glutamate-induced neurotoxicity

Association of an interleukin 1 alpha polymorphism with Alzheimer's disease

Assessing health-related quality of life in patients with Parkinson's disease in a prospective longitudinal study

Pharmacotherapy of Parkinson's disease in Germany

Evaluation of healthcare utilization and health status of patients with Parkinson's disease treated with deep brain stimulation of the subthalamic nucleus

Minocycline Prevents Nigrostriatal Dopaminergic Neurodegeneration in the MPTP Model of Parkinson's Disease

Activation mapping in essential tremor with functional magnetic resonance imaging

Involvement of a Caspase‐3‐Like Cysteine Protease in 1‐Methyl‐4‐Phenylpyridinium‐Mediated Apoptosis of Cultured Cerebellar Granule Neurons

Peptide inhibitors of caspase-3-like proteases attenuate 1-methyl-4-phenylpyridinum-induced toxicity of cultured fetal rat mesencephalic dopamine neurons

Health-related quality of life and healthcare utilisation in patients with Parkinson's disease: Impact of motor fluctuations and dyskinesias

A polymorphism in the cystatin C promoter region is not associated with an increased risk of AD

Lack of apolipoprotein E dramatically reduces amyloid β-peptide deposition

Costs of drug treatment in Parkinson's disease

Activation of a Caspase 3-Related Cysteine Protease is Required for Glutamate-Mediated Apoptosis of Cultured Cerebellar Granule Neurons

The NF- κB/Rel family of proteins mediates A β-induced neurotoxicity and glial activation

Long-term disease-related costs 4 years after stroke or TIA in Germany

Caspase-3-like proteases and 6-hydroxydopamine induced neuronal cell death

International guide to drugs for Parkinson's disease

The economic impact of Parkinson's disease. An estimation based on a 3-month prospective analysis

Characterization of histamine receptors in the ureter of the dog

Langzeitkrankheitskosten 4 Jahre nach Schlaganfall oder TIA in Deutschland

Apolipoprotein E is essential for amyloid deposition in the APP(V717F) transgenic mouse model of Alzheimer's disease

New approaches to rapid onset antidepressants

Suchergebnisse filtern